Perioperative cardiovascular assessment and management of liver transplant patients

Area of Science:

• Cardiology
• Hepatology
• Transplantation Medicine

Background:

• Cardiovascular disease (CVD) is a major cause of death in end-stage liver disease (ESLD) patients, particularly around liver transplantation (LT).
• Current cardiovascular risk assessment and management strategies for ESLD patients are inconsistent.
• This review synthesizes recent findings on cardiovascular issues in ESLD patients undergoing LT.

Purpose of the Study:

• To review recent findings on cardiovascular disease in ESLD patients undergoing LT.
• To highlight the need for standardized cardiovascular evaluation and optimization in this population.
• To emphasize the importance of a multidisciplinary approach to cardiovascular management.

Main Methods:

• Literature review of recent findings on cardiovascular disease in ESLD patients.
• Synthesis of data on the interplay between cirrhosis, portal hypertension, and cardiovascular dysfunction.
• Analysis of advances in pretransplant screening and risk stratification.

Main Results:

• Cirrhosis contributes to cardiovascular dysfunction, including cirrhotic cardiomyopathy, coronary artery disease, arrhythmias, and heart failure.
• Pretransplant screening is shifting towards risk-stratified approaches using noninvasive imaging and selective coronary angiography.
• Cardiovascular complications are common during and after LT, and immunosuppression can increase long-term CVD risk.

Conclusions:

• A multidisciplinary approach is essential for managing cardiovascular health in ESLD patients undergoing LT.
• Standardized preoperative protocols, refined risk stratification, and evidence-based postoperative monitoring are critical for reducing CVD complications.
• Future research should focus on optimizing interventions, developing consensus guidelines, and improving long-term cardiovascular care for LT recipients.